RLS Global AB (publ)

ST:RLS Sweden Drug Manufacturers - Specialty & Generic
Market Cap
$3.18 Million
Skr35.62 Million SEK
Market Cap Rank
#33165 Global
#514 in Sweden
Share Price
Skr0.45
Change (1 day)
+0.00%
52-Week Range
Skr0.45 - Skr0.45
All Time High
Skr14.83
About

RLS Global AB (publ), a medical technology company, develops and sells products for minimally invasive treatment in Sweden. Its products include ChloraSolv that is used for the treatment of chronic diabetic foot and leg ulcers for diabetic patients; and CariSolv, a gel used for removing caries. RLS Global AB (publ), was founded in 1996 and is based in Mölndal, Sweden.

RLS Global AB (publ) (RLS) - Total Liabilities

Latest total liabilities as of June 2023: Skr6.90 Million SEK

Based on the latest financial reports, RLS Global AB (publ) (RLS) has total liabilities worth Skr6.90 Million SEK as of June 2023.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

RLS Global AB (publ) - Total Liabilities Trend (2006–2022)

This chart illustrates how RLS Global AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

RLS Global AB (publ) Competitors by Total Liabilities

The table below lists competitors of RLS Global AB (publ) ranked by their total liabilities.

Company Country Total Liabilities
SAFRAN - Dusseldorf Stock Exchang
DU:SEJ1
Germany €38.38 Billion
UET United Electronic Technology AG
XETRA:CFC
Germany €49.88 Million
Zoned Properties Inc
OTCQB:ZDPY
USA $10.55 Million
Adroit Infotech Limited
NSE:ADROITINFO
India ₹275.75 Million
Recharge Metals Ltd
AU:REC
Australia AU$199.63K
BurTech Acquisition Corp. Warrants
NASDAQ:BRKHW
USA $20.44 Million
LPL FIN HLDG
BE:7LI
Germany €9.17 Billion
Marin Software Inc
NASDAQ:MRIN
USA $4.50 Million

Liability Composition Analysis (2006–2022)

This chart breaks down RLS Global AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.13 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.42 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.29 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how RLS Global AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for RLS Global AB (publ) (2006–2022)

The table below shows the annual total liabilities of RLS Global AB (publ) from 2006 to 2022.

Year Total Liabilities Change
2022-12-31 Skr6.67 Million -0.80%
2021-12-31 Skr6.72 Million +34.94%
2020-12-31 Skr4.98 Million -16.76%
2019-12-31 Skr5.98 Million -6.64%
2018-12-31 Skr6.41 Million -11.64%
2017-12-31 Skr7.25 Million -20.13%
2016-12-31 Skr9.08 Million +35.28%
2015-12-31 Skr6.71 Million +149.83%
2014-12-31 Skr2.69 Million -22.91%
2013-12-31 Skr3.49 Million +47.19%
2012-12-31 Skr2.37 Million +66.91%
2011-12-31 Skr1.42 Million -80.81%
2010-12-31 Skr7.39 Million -90.08%
2009-12-31 Skr74.53 Million +20.66%
2008-12-31 Skr61.77 Million -5.38%
2007-12-31 Skr65.28 Million +518.47%
2006-12-31 Skr10.55 Million --